🔗 Visit the ClinicalTrials.gov page for NCT02092350
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study. | Lancet | 2015 | 2.91 |
| 2 | HIV and HCV Medications in End-Stage Renal Disease. | Semin Dial | 2015 | 0.82 |
| 3 | Impact of new treatment options for hepatitis C virus infection in liver transplantation. | World J Gastroenterol | 2015 | 0.77 |
| 4 | Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates. | J Transplant | 2015 | 0.76 |
| 5 | Elbasvir/Grazoprevir. | Hosp Pharm | 2016 | 0.75 |
| 6 | Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead? | Kidney Int | 2015 | 0.75 |